These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 32657101)

  • 21. Acute urine retention induced by ceftriaxone.
    Akl KF; Masri AT; Hjazeen MM
    Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1226-8. PubMed ID: 22089789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Factors for Ceftriaxone-Associated Pseudolithiasis in Adults.
    Matsumi A; Tomoda T; Terasawa H; Fujii Y; Yamazaki T; Uchida D; Matsumoto K; Horiguchi S; Tsutsumi K; Kato H
    Digestion; 2023; 104(4):313-319. PubMed ID: 36907172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of ceftriaxone-associated pseudolithiasis in an adult patient that disappeared after the discontinuation of ceftriaxone].
    Tomoda T; Ueki T; Saito S; Tatsukawa M; Nawa T; Hamamoto H; Endo H; Yabushita K; Shimoe T; Sakaguchi K
    Nihon Shokakibyo Gakkai Zasshi; 2013 Aug; 110(8):1481-6. PubMed ID: 23912008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodialysis as a Risk Factor for Ceftriaxone-Associated Pseudolithiasis in Adults.
    Ubukata M; Ohsawa I; Suzuki H; Asao R; Nakamura Y; Nishida H; Nakamura M; Nitta K; Goto Y; Gotoh H
    Ther Apher Dial; 2020 Aug; 24(4):393-399. PubMed ID: 31626369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computed tomography findings of ceftriaxone-associated biliary pseudocholelithiasis in adults.
    Yoshida R; Yoshizako T; Katsube T; Kitagaki H
    Jpn J Radiol; 2019 Dec; 37(12):826-831. PubMed ID: 31654330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ceftriaxone-induced biliary pseudolithiasis and urinary bladder sludge.
    Acun C; Erdem LO; Sogut A; Erdem CZ; Tomac N; Gundogdu S
    Pediatr Int; 2004 Jun; 46(3):368-70. PubMed ID: 15151561
    [No Abstract]   [Full Text] [Related]  

  • 27. Ceftriaxone-associated biliary pseudolithiasis in paediatric surgical patients.
    Ceran C; Oztoprak I; Cankorkmaz L; Gumuş C; Yildiz T; Koyluoglu G
    Int J Antimicrob Agents; 2005 Mar; 25(3):256-9. PubMed ID: 15737522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudolithiasis due to ceftriaxone treatment for meningitis in children: report of 8 cases.
    Araz N; Okan V; Demirci M; Araz M
    Tohoku J Exp Med; 2007 Mar; 211(3):285-90. PubMed ID: 17347554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gallbladder and urinary tract precipitations associated with ceftriaxone therapy in children: a prospective study.
    Acun C; Erdem LO; Söğüt A; Erdem CZ; Tomaç N; Gündoğdu S; Cavuldak S
    Ann Trop Paediatr; 2004 Mar; 24(1):25-31. PubMed ID: 15005963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ceftriaxone-associated acute gallbladder enlargement - an unexpected diagnosis in the child with urinary tract infection.
    Krzemień G; Książczyk T; Szmigielska A; Bombiński P; Roszkowska-Blaim M; Werner B; Brzewski M
    Dev Period Med; 2015; 19(2):182-5. PubMed ID: 26384120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gallstones in association with the use of ceftriaxone in children].
    Rodríguez Rangel DA; Pinilla Orejarena AP; Bustacara Diaz M; Henao García L; López Cadena A; Montoya Camargo R; Moreno LA
    An Pediatr (Barc); 2014 Feb; 80(2):77-80. PubMed ID: 23759541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Four cases of ceftriaxone-associated biliary pseudolithiasis].
    Niwa M; Tochii K
    Nihon Shokakibyo Gakkai Zasshi; 2016; 113(2):281-8. PubMed ID: 26853988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Case report; a case of biliary pseudolithiasis associated with ceftriaxone].
    Hanata N; Imamura T; Koyama R; Koizumi Y; Tamura T; Ito J; Takeuch K
    Nihon Naika Gakkai Zasshi; 2012 Oct; 101(10):2955-7. PubMed ID: 23214106
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ceftriaxone-associated biliary pseudolithiasis in a child].
    Wang YQ
    Zhonghua Er Ke Za Zhi; 2005 Apr; 43(4):251. PubMed ID: 15924712
    [No Abstract]   [Full Text] [Related]  

  • 35. Anuria and abdominal pain induced by ceftriaxone-associated ureterolithiasis in adults.
    Li ZL; Li HL; Chen HW; Li HC; Zhang P; Wang ZM; Chong T
    Int Urol Nephrol; 2013 Feb; 45(1):73-6. PubMed ID: 23180444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ceftriaxone-associated gallbladder pseudolithiasis: report of one case.
    Wen HH; Huang YK; Zheng GL
    Acta Paediatr Taiwan; 2004; 45(5):290-2. PubMed ID: 15868813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversible symptomatic biliary obstruction associated with ceftriaxone pseudolithiasis.
    Zinberg J; Chernaik R; Coman E; Rosenblatt R; Brandt LJ
    Am J Gastroenterol; 1991 Sep; 86(9):1251-4. PubMed ID: 1882806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ceftriaxone-associated biliary pseudolithiasis in a child with nephrotic syndrome].
    Zheng FY; Xing Y; Lu S; Liu DM
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Aug; 15(8):696-7. PubMed ID: 23965889
    [No Abstract]   [Full Text] [Related]  

  • 39. Risk factors of ceftriaxone-associated biliary pseudolithiasis in adults: influence of renal dysfunction.
    Imafuku A; Sawa N; Sekine A; Kawada M; Hiramatsu R; Yamanouchi M; Hasegawa E; Hayami N; Hoshino J; Ubara Y; Takaichi K
    Clin Exp Nephrol; 2018 Jun; 22(3):613-619. PubMed ID: 29027036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biliary pseudolithiasis in a child associated with 2 days of ceftriaxone therapy.
    Blais C; Duperval R
    Pediatr Radiol; 1994; 24(3):218-9. PubMed ID: 7936805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.